Key Details
Price
$6.88Annual ROE
0.95%Beta
0.50Events Calendar
Next earnings date:
Feb 07, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Sept 10, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q1 2025 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Paula Savanti – Head-Investor Relations Federico Trucco – Chief Executive Officer Enrique López Lecube – Chief Financial Officer Conference Call Participants Ben Klieve – Lake Street Capital Markets Kristen Owen – Oppenheimer Kemp Dolliver – Brookline Capital Markets Andrew Steinhardt – Canaccord Genuity Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Bioceres Crop Solutions Fiscal First Quarter 2025 Financial and Operational Results Call.
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons.
For retail investors, momentum and trends can be drivers of investment decisions and interest. The stocks that analysts and other investors are talking about most may hold a special appeal (although timing the market and ensuring that you buy in at an appropriate time are difficult challenges).
Bioceres' 4Q24 results disappointed, with flat profitability and a 15% stock drop, driven by a bear market in agricultural commodities and commercialization challenges for HB4 products. The company's debt rose, particularly short term, with unclear maturity risks, and profitability challenges persisted despite top-line growth. Bioceres is shifting tactics for HB4, reducing the priority of its identity-protected program to manage working capital and focusing more on its bio solutions segment.
ENDEAVOUR ACHIEVES COMMERCIAL PRODUCTION AT BIOX EXPANSION AND LAFIGUÉ GROWTH PROJECTS HIGHLIGHTS: • Commercial production achieved on budget and on schedule at the Sabodala-Massawa BIOX Expansion and the Lafigué mine on 1 August 2024 • Organic growth phase completed improving the quality of the portfolio and underpinning the transition to a phase focused on free cash flow generation • BIOX Expansion achieved commercial production; operating with 94% plant availability at 80% of nameplate capacity, with average recoveries of above 72% during July and August • Lafigué mine achieved commercial production only one month after the first gold pour; operating with 87% plant availability at 72% of nameplate capacity, with average recoveries of above 95% during August • The Group remains on track to achieve its full-year production guidance with AISC near the top end of the guided range London , 13 September 2024 – Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) (“Endeavour”, the “Group” or the “Company”) is pleased to announce that it has achieved commercial production at both its Sabodala-Massawa BIOX Expansion in Senegal and at its Lafigué mine in Côte d'Ivoire, effective as of 1 August 2024. Both projects have been completed on budget and on schedule, with the full ramp up to nameplate capacity underway.
Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q4 2024 Earnings Conference Call September 10, 2024 8:30 AM ET Company Participants Paula Savanti - Head of IR Federico Trucco - CEO Enrique Lopez Lecube - CFO Conference Call Participants Ben Klieve - Lake Street Capital Markets Kristen Owen - Oppenheimer Kemp Dolliver - Brookline Capital Markets Austin Moeller - Canaccord Scott Fortune - ROTH Capital Partners Operator Good morning. Welcome to today's Bioceres Crop Solutions, Fiscal Fourth Quarter and Full Year 2024 Financial Results Conference call.
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter and fiscal year ended June 30, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All.
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) will be hosting its Q3 2024 Results Conference Call on May 14, 2024 at 8:30 AM ET. Participants include Paula Savanti, Federico Trucco, and Enrique Lopez Lecube. Conference Call Participants include Kristen Owen, Ben Klieve, Scott Fortune, and Kemp Dolliver. The operator for the call is Carla. Welcome to the Bioceres Crop Solutions Fiscal Third Quarter 2024 Financial Results Conference Call.
One of the best stocks for financial freedom over the past 30 years is Monster Beverage (NASDAQ: MNST ). Between Feb. 14, 1994, and Feb. 14, 2024, the energy drink maker's stock appreciated around 200,000%.
Bioceres Crop Solutions Corp. (BIOX) Q2 2024 Earnings Call Transcript
FAQ
- What is the primary business of Bioceres Crop Solutions?
- What is the ticker symbol for Bioceres Crop Solutions?
- Does Bioceres Crop Solutions pay dividends?
- What sector is Bioceres Crop Solutions in?
- What industry is Bioceres Crop Solutions in?
- What country is Bioceres Crop Solutions based in?
- When did Bioceres Crop Solutions go public?
- Is Bioceres Crop Solutions in the S&P 500?
- Is Bioceres Crop Solutions in the NASDAQ 100?
- Is Bioceres Crop Solutions in the Dow Jones?
- When was Bioceres Crop Solutions's last earnings report?
- When does Bioceres Crop Solutions report earnings?
- Should I buy Bioceres Crop Solutions stock now?